RUO supplier

BioLongevity Labs

Official RUO, company, and public COA pages reviewed

Unclaimed profileReviewed Jul 12, 2026

Deep research review

Company status and documentation

BioLongevity Labs, operated by F2 Nutrition LLC, publishes a broad public COA database and names SafeCert Labs on its current home page. The site also claims three-laboratory testing, but does not consistently identify all three laboratories for each lot. Catalog-size and GMP wording conflict across official pages.

What this review did not check: Official pages contain conflicting catalog-size and manufacturing-language claims.

Findings

What the public record shows

The product catalog is publicly browseable, while purchasing research products requires an account.

Limit: The current catalog count is inconsistent across pages.

Observed Jul 12, 2026

The public COA database lists many products and report cards across current and historical records.

Limit: The index does not clearly show three laboratories for every current lot.

Observed Jul 12, 2026

A BPC-157 10 mg report for accession 2502270002 reports 10 mg quantity, 99.03% purity, BPC-157 identity, and white lyophilized appearance.

Limit: The extracted report text does not visibly name SafeCert or a second and third laboratory. Results apply only to the listed sample.

Observed Jul 12, 2026

Named relationships

Laboratories named on public records

SafeCert Labs

named-on-current-home-page

Limit: The home page says every batch includes a SafeCert COA, but the reviewed sample's extracted text does not identify the lab. CLIA status alone does not establish the scope of a specific research-peptide method.

Observed Jul 12, 2026

Search limits

Regulatory and community checks

No exact-name FDA warning letter, recall, or enforcement page surfaced in the limited FDA-site search.

Limit: Search absence is not regulatory clearance.

Observed Jul 12, 2026

A brand-named subreddit thread contains mixed anecdotes and affiliate-code behavior.

Limit: Brand-specific and commercially influenced discussion is not analytical evidence and should not drive a reputation score.

Observed Jul 12, 2026

Open company questions

What is still unresolved

  • Which three laboratories test each current lot?
  • Where are all three reports for each current lot?
  • Which facility or partner performs synthesis?
  • What is the correct current catalog count?
  • Which certification scope supports the facility and laboratory claims?
  • Are sterility, endotoxin, and contaminant fields present for every lot or only selected panels?

Supplier documentation profile

Supplier type
Direct RUO catalog
Documentation
Public analytical-document library
RUO language
The official policy states that research products are for research and development use only and are not intended to diagnose, treat, cure, or prevent disease.
Testing claims
The supplier states that batches are reviewed by three independent laboratories using methods including HPLC and LC-MS, with documentation available before purchase.

Observable documentation fields

74/100 public-record coverage

This measures fields in normalized public records. It does not score product quality, sterility, legal compliance, or suitability.

1 normalized report
ruo Policy10
official Sources10
documentation Access15
public Reports4
identity10
purity10
net Content10
endotoxin0
sterility0
named Laboratory5

Normalized batch records

Testing reports

Each row becomes a stacked record on smaller screens. Coverage means the field appears in the source record. It is not a Peptide Report pass or independent reproduction.

ProductBatchLaboratoryDateMethodsFields presentRecord
BPC-157 10 mg research material2502270002Freedom Diagnostics TestingFeb 28, 2025HPLC, LC-MSidentity, purity, net ContentSource report

Observed catalog records

Products connected to evidence records

Editorial record

The site uses conflicting 80-plus and 150-plus catalog counts and mixes GMP-certified with cGMP-aligned language. These statements remain unresolved supplier claims until facility and accreditation records are identified.

Profile ownership: unclaimed. Company representatives will be able to propose identity and catalog updates without changing editorial or regulatory records.

Official sources

Directory discovery references

These secondary directories helped identify the company. Their rankings and verification labels are not adopted by Peptide Report.